News Daily News FDA Drops REMS Requirement for Antihypertensive Aprocitentan Michael O'Riordan April 09, 2025
News Opinion Off Script Evoque and Patisiran: A Tale of Two Regulatory Journeys Sanjay Kaul, MD March 29, 2024
News Daily News Abiomed Recalls Labeling for Left-Sided Impella Pumps: FDA Caitlin E. Cox March 21, 2024
News Daily News FDA Scolds Abiomed for Not Seeking a PMA for Its Web-Based User Portal Caitlin E. Cox October 17, 2023
News Daily News Medical Devices Cleared on Faulty Predicates More Likely to be Recalled Michael O'Riordan January 17, 2023
News Daily News Impella RP Mortality Rate No Longer a Concern, FDA Says Caitlin E. Cox December 05, 2022
News Daily News FDA: Class I Recall of Cobalt and Crome ICDs and CRT-Ds Due to Reduced-Energy Shock L.A. McKeown August 19, 2022
News Daily News Lotus Edge TAVR Device Recalled and Discontinued Worldwide Michael O'Riordan November 18, 2020
News Daily News FDA: Obesity Drug Lorcaserin Exits US Market Over Cancer Concerns Shelley Wood February 14, 2020
News Daily News European Regulators Approve First Transcatheter MV Replacement Device Michael O'Riordan January 30, 2020
News Daily News FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl Michael O'Riordan November 14, 2019
News Daily News New Recall for Maquet/Datascope IABPs Due to Potential Battery Failure Marcus A. Banks July 24, 2019
News Daily News FDA Provides Update on Poorer Survival With Impella RP in Postmarket Setting Todd Neale May 21, 2019
News Daily News FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients L.A. McKeown March 21, 2019
News Daily News FDA Warns Healthcare Providers of Potential Rise in Death Rate With Impella RP Caitlin E. Cox February 04, 2019